Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Michael Farkas, PhD

  • Functional characterization of a novel splice variant in PRPF31. Michael Farkas (Principal Investigator). Foundation Fighting Blindness. $154,446. 6/1/2015-5/1/2017.

Steven Fliesler, PhD

Xiuqian Mu, MD, PhD

  • Regulatory mechanisms for retinal ganglion cell genesis. Xiuqian Mu (Principal Investigator). National Institutes of Health. $1,960,167. 9/1/2017-5/1/2022.
  • Generation of retinal ganglion cells by direct reprograming. Xiuqian Mu (Principal Investigator). BrightFocus Foundation. $150,000. 6/1/2016-5/1/2018.

Sangita Patel, MD, PhD

  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Sangita Patel (Co-Investigator), Michael Duffey (Co-Investigator), Mark Parker (Principal Investigator). National Institutes of Health. $1,972,804. 2/1/2018-1/1/2023.

Sarah Zhang, MD

  • Targeting Neuroinflammation for RGC Protection in Glaucoma. Sarah Zhang (Principal Investigator). BrightFocus Foundation. $200,000. 7/1/2019-6/1/2021.
  • ER stress and diabetic retinopathy. Sarah Zhang (Principal Investigator). NIH, NEI. $85,750. 9/1/2018-8/1/2020.
  • ER stress and diabetic retinopathy. Sarah Zhang (Principal Investigator), Jun Qu (Co-Principal Investigator). NIH/NEI. $1,590,636. 9/1/2015-8/1/2020.